Access to Rare Indications Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Dec 7, 2021)
Access to Rare Indications Act of 2021
This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.
What just happenedDec 8, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseDec 7, 2021
- Dec 8, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Dec 7, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Dec 7, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Dec 7, 2021IntroReferralIntro-H
Introduced in House
- Dec 7, 2021IntroReferral1000
Introduced in House